-
241
The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study
Published 2020-06-01“…Systemic glucocorticoid, cyclophosphamide, hydroxychloroquine (HCQ), methotrexate, and azathioprine were considered the main medication indices. …”
Get full text
Article -
242
Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study.
Published 2022-01-01“…The geometric means were 676.5.7 U/ml in the biological therapy group, 614.4 U/ml in the azathioprine group and 500.1 U/ml in the combination therapy group of patients four weeks after 2nd dose. …”
Get full text
Article -
243
Comparison Effect of Prescription Drugs on the Occurrence and the Number of Attacks in Patients with Multiple Sclerosis
Published 2018-01-01“…In women, fingolimod drugs, glatiramer acetate, and azathioprine had less effect on the number of attacks, respectively. …”
Get full text
Article -
244
Transdermal liposomes for treatment of atopic dermatitis
Published 2019“…Current treatment methods include the use of systematic immunosuppressant, Cyclosporine and Azathioprine. In recent studies, Methotrexate (MTX) has shown to be a potential treatment of eczema. …”
Get full text
Final Year Project (FYP) -
245
Sustained remission of severe resistant autoimmune neutropenia with Campath-1H.
Published 1997“…We report the course of a patient with severe autoimmune neutropenia in whom only transient responses occurred with corticosteroids, antilymphocyte globulin and granulocyte-colony stimulating factor, and who was resistant to treatment with azathioprine, cyclosporin and intravenous immunoglobulin. …”
Journal article -
246
The management of primary sclerosing cholangitis.
Published 1998“…Although the role of cupruretics, immunosuppressants (corticosteroids, azathioprine, tacrolimus, methotrexate), antifibrogenic agents, and ursodeoxycholic acid in the treatment of primary sclerosing cholangitis is reviewed, none of these agents has been shown to retard or reverse the rate of disease progression. …”
Journal article -
247
Livedoid Vasculitis in a Patient With Sjogren Syndrome Successfully Treated With Methotrexate
Published 2022-03-01“…Case Description: We present a case of a 66-year-old female with Sjogren syndrome cutaneous vasculitis in whom combination treatment with Rituximab and Azathioprine failed to show a favorable response. However, methotrexate proved to be an excellent alternative. …”
Get full text
Article -
248
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.
Published 1979“…A collaborative study including centres in the United Kingdom, Australia, and New Zealand was instituted in 1970 to determine the incidence of cancer in patients treated for at least three months with azathioprine, cyclophosphamide, or chlorambucil. Follow-up of 3823 renal transplant recipients showed an almost 60-fold increase of non-Hodgkin's lymphoma together with an excess of squamous-cell skin cancer and mesenchymal tumours. …”
Journal article -
249
Gout in pediatric renal transplant recipients.
Published 2010“…To prevent severe bone marrow depletion, the dosage of azathioprine, an immunosupressant drug, was reduced by 50% to prevent interaction with allopurinol. …”
Journal article -
250
A review article of inflammatory bowel disease treatment and pharmacogenomics
Published 2023-03-01“…This review aims to summarize the pharmacogenetics of biologics approved for IBD and the correlation with azathioprine-metabolizing enzymes and adverse reactions, therefore highlighting a likely relationship between particular polymorphisms and therapeutic response. …”
Get full text
Article -
251
Group I pharmaceuticals of IARC and associated cancer risks: systematic review and meta-analysis
Published 2024-01-01“…Cyclosporine and azathioprine reported increased skin cancer risk (SRR = 1.32, 95% CI 1.07–1.62; SRR = 1.56, 95% CI 1.25–1.93) compared to non-use. …”
Get full text
Article -
252
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic...
Published 2024-02-01“…High-quality evidence of the following associations was identified: elevated liver enzymes (6 studies) and folate non-supplementation (3 studies) are prognostic factors for hepatotoxicity in those treated with methotrexate; that mercaptopurine (vs azathioprine) (3 studies) was a prognostic factor for hepatotoxicity in those treated with thiopurines; that mercaptopurine (vs azathioprine) (3 studies) and poor-metaboliser status (4 studies) were prognostic factors for cytopenia in those treated with thiopurines; and that baseline elevated liver enzymes (3 studies) are a prognostic factor for hepatotoxicity in those treated with anti-tumour necrosis factors. …”
Get full text
Article -
253
Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescrib...
Published 2022-12-01“…Objective To investigate monthly prescription refills for common immunosuppressive/immunomodulatory therapy (sulfasalazine, hydroxychloroquine, azathioprine, methotrexate, leflunomide) prescriptions in England during the complete first wave of the COVID-19 pandemic. …”
Get full text
Article -
254
CLASSICAL SEROLOGICAL MARKERS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE IN BRAZIL
Published 2021-12-01“…The proportion of patients testing positive for ASCA IgA (76.2%) and ASCA IgG (94.4%) markers was also significantly higher in the CD group than in the control Group (P<0.001), and such positivity correlated significantly with the use of immunomodulatory medications such as azathioprine and anti-tumor necrosis factor agents (azathioprine 38.9%, anti-TNF 55.6%; P=0.002). …”
Get full text
Article -
255
Assessment of the Prevalence and Risk Factors Associated With Glucocorticoid-Induced Diabetes Mellitus in Pemphigus Vulgaris Patients
Published 2017-08-01“…Although the group who received azathioprine was associated with increased incidence of diabetes, the overall corticosteroid dose in this group was significantly higher than the other group (P=0.012), and controversy with other studies could be because of difference in corticosteroid dosage and small number of patients. …”
Get full text
Article -
256
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Published 2017“…De-escalation was possible for adalimumab EW±azathioprine if failure criteria were not met. The primary endpoint of mucosal healing (CDEIS<4) with absence of deep ulcers was assessed 48 weeks post-randomisation.…”
Journal article -
257
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome
Published 2023-07-01“…Cirrhosis, obesity, prior azathioprine use, and concurrent autoimmune diseases were significantly associated with cancer in PBC.…”
Get full text
Article -
258
Clinical and Endoscopic Response to Anti-Tumor Necrosis Factor-Alpha Antibody Therapy in a Patient With Cronkhite-Canada Syndrome
Published 2023-06-01“…The use of infliximab and azathioprine led to promising remission of his symptoms.…”
Get full text
Article -
259
Treatment of Autoimmune Hepatitis
Published 2023-02-01“…Glucocorticoids and azathioprine are the first line of treatment. Alternative first-line treatments include budesonide or mycophenolate mofetil (MMF). …”
Get full text
Article -
260
Cutaneous mucinosis in mixed connective tissue disease*
Published 2013-08-01“…Both cases had skin lesions with no other clinical or laboratorial manifestations, with clinical response to azathioprine in one, and to an association of chloroquine and prednisone in the other.…”
Get full text
Article